Degenerative Myelopathy (DM) is one of the most frequently diagnosed conditions in the breed within the Chesapeake Bay Retriever. Common indicators include progressive hind limb weakness, knuckling of hind paws, and dragging hind legs. DM is a progressive, non-painful spinal cord disease caused by a mutation in the SOD1 gene. It begins with hind limb weakness and ataxia, progressing to complete paralysis and eventually fore limb involvement. It is analogous to ALS in humans. It typically becomes apparent at 8-14 years. The large frame of the Chesapeake Bay Retriever can accelerate progression in weight-bearing conditions, making early diagnosis particularly valuable. This condition has a hereditary component — prospective owners should request documentation of health screening from the breeder. Treatment costs are estimated at £500-£3,000/year, making comprehensive pet insurance a practical consideration.
If your Chesapeake Bay Retriever is showing any of these signs, consult your veterinarian promptly.
There is no cure or disease-modifying treatment. Intensive physiotherapy and hydrotherapy can slow decline and maintain quality of life. Wheelchairs improve mobility in later stages.
Estimated Treatment Cost
£500-£3,000/year
Costs vary by severity, location, and treatment path. Pet insurance is strongly recommended.
A diet formulation designed to support Chesapeake Bay Retrievers managing Degenerative Myelopathy (DM). Formulated with high-quality protein and easily digestible ingredients.
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.
Chesapeake Bay Retrievers with Degenerative Myelopathy (DM) benefit from consistent supplementation. This vet-formulated blend supports overall wellbeing and may complement prescribed treatment.
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.
Prevalence and severity can vary significantly between breeds.